Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
August 16, 2024 09:00 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA
Nevada Lithium Announces Closing of $6 Million Private Placement led by Strategic Investor Marcel Boekhoorn
August 16, 2024 08:00 ET
|
Nevada Lithium Resources Inc.
VANCOUVER, British Columbia, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Nevada Lithium Resources Inc. (CSE: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company”) is pleased to announce that it...
Aduro Clean Technologies Announces Effective Date for Share Consolidation and Conversion of Class B Special Warrants
August 16, 2024 07:09 ET
|
Aduro Clean Technologies Inc.
Aduro Clean Technologies Announces Effective Date for Share Consolidation and Conversion of Class B Special Warrants
Rivalry to Report Second Quarter 2024 Results on August 29, Announces Management Change
August 16, 2024 07:00 ET
|
Rivalry Corp.
Rivalry announces Q2 2024 reporting date of August 29 and CFO change
ChampionX Declares Quarterly Dividend
August 16, 2024 07:00 ET
|
ChampionX Corporation
THE WOODLANDS, Texas, Aug. 16, 2024 (GLOBE NEWSWIRE) -- ChampionX Corporation (Nasdaq: CHX) announced today its Board of Directors has declared a regular quarterly dividend of $0.095 per share on...
EnWave to Report Third Quarter Financial Results on August 22, 2024 and Host Investor Conference Call
August 15, 2024 20:30 ET
|
EnWave Corporation
VANCOUVER, British Columbia, Aug. 15, 2024 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today it will report its financial results for the...
NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process
August 15, 2024 16:03 ET
|
NurExone Biologic Inc
NurExone’s reliable production from diverse biological sources allows NurExone to optimize exosome production with consistency and efficiency
VCI Global to Announce First Half 2024 Financial Results on August 19th, 2024
August 15, 2024 10:28 ET
|
VCI Global Limited
KUALA LUMPUR, Malaysia, Aug. 15, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global”, “VCIG”, or the “Company”) today announced that it will release its...
Lifeist Chairman’s Letter to Shareholders
August 15, 2024 08:24 ET
|
Lifeist Wellness Inc.
Chairman’s Letter to Shareholders